What is the treatment for a patient with a history of hypertension and possible bleeding disorders who experienced a subconjunctival hemorrhage (burst blood vessels in the conjunctiva) after an airplane landing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Subconjunctival Hemorrhage After Airplane Landing in a Patient with Hypertension and Possible Bleeding Disorder

For a patient with subconjunctival hemorrhage after airplane landing, reassurance and symptomatic treatment with NSAIDs or acetaminophen is the appropriate management, as routine screening for bleeding disorders is not indicated even in patients with recurrent episodes. 1, 2

Immediate Management

The primary treatment is pain control and reassurance, as subconjunctival hemorrhage is a benign, self-limited condition. 3, 4

  • Administer NSAIDs (ibuprofen) or acetaminophen at fixed intervals for any associated ocular discomfort, as pain is easier to prevent than treat 5
  • NSAIDs are superior to acetaminophen alone because they address both pain and inflammation 5
  • Initiate preservative-free artificial tears (if using more than 4 times daily) to address ocular surface dryness from low-humidity cabin air exposure 5

No Need for Bleeding Disorder Workup

The prevalence of hemostatic abnormalities in patients with spontaneous subconjunctival hemorrhage is not different from the general population, making routine screening unnecessary. 1, 2

  • A study of 105 patients with recurrent spontaneous subconjunctival hemorrhage found no increased prevalence of hemostatic alterations compared to healthy controls 2
  • Type I von Willebrand disease was diagnosed in only 3.8% of patients with subconjunctival hemorrhage, which is not statistically different from the normal population frequency 1
  • Hemostatic screening or second-level coagulation tests are of no use in patients with recurrent subconjunctival hemorrhage who have no other bleeding manifestations 2

When to Consider Further Evaluation

Further workup is only warranted if the hemorrhage is recurrent or persistent, or if there are other systemic bleeding manifestations. 3

  • Evaluate for uncontrolled hypertension, as systemic vascular diseases are common risk factors in elderly patients 3
  • Consider medication review for anticoagulants, antiplatelet agents, or NSAIDs that may contribute to bleeding 2
  • Assess for systemic or ocular malignancies only if hemorrhages are truly recurrent and persistent 3

Expected Course and Follow-up

Subconjunctival hemorrhage typically resolves spontaneously within 1-2 weeks without intervention. 3, 4

  • The blood appears as sudden, painless bright red discoloration under the clear conjunctiva 4
  • No specific treatment accelerates resolution 3
  • Reassure the patient that this is a benign condition with excellent prognosis 3, 4

Common Pitfalls to Avoid

  • Do not order routine coagulation studies or bleeding disorder workup for isolated subconjunctival hemorrhage, as the yield is extremely low and not cost-effective 1, 2
  • Do not prescribe antibiotics, as subconjunctival hemorrhage is not infectious 5
  • Do not use artificial tears with preservatives if frequent applications are needed (>4 times/day), as preservatives can worsen the ocular surface 5

References

Research

Subconjunctival hemorrhage: risk factors and potential indicators.

Clinical ophthalmology (Auckland, N.Z.), 2013

Research

Subconjunctival hemorrhage--something more you should know.

Insight (American Society of Ophthalmic Registered Nurses), 1995

Guideline

Management of Global Ocular Pain After Air Current Exposure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.